Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial

Clicks: 210
ID: 272645
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
These pilot data suggest that L. rhamnosus GG is safe and efficacious in preventing VAP in a select, high-risk ICU population. Clinical trial registered with www.clinicaltrials.gov (NCT00613795).
Reference Key
le2010americanprobiotic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Morrow LE;Kollef MH;Casale TB;;
Journal american journal of respiratory and critical care medicine
Year 2010
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/20522788
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine safety research support non-u.s. gov't adult female male N.I.H. Extramural aged middle aged Prospective Studies 80 and over Randomized Controlled Trial Double-Blind Method Survival Analysis diarrhea / prevention & control pneumonia pilot projects diarrhea / microbiology intention to treat analysis probiotics / therapeutic use* probiotics / administration & dosage clostridioides difficile pmid:20522788 pmc2970846 doi:10.1164/rccm.200912-1853oc lee e morrow marin h kollef thomas b casale clostridium infections / prevention & control lactobacillus rhamnosus* ventilator-associated / prevention & control*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.